Nawrocki, US
Andrew J. Nawrocki, Morgantown, WV US
Patent application number | Description | Published |
---|---|---|
20120003090 | AIRFOIL FOR CIRCULATION CONTROLLED VERTICAL AXIS WIND TURBINES - A airfoil blade for vertical axis wind turbines is presented. The airfoil blade comprises an internal cavity, an upper blowing slot disposed on the airfoil blade, and a lower blowing slot on the airfoil blade, and further comprises a valve means for variably connecting the outside air to the internal cavity through the blowing slots to selectively produce a variable lift-drag condition of said airfoil blade. | 01-05-2012 |
20120014792 | CIRCULATION CONTROLLED VERTICAL AXIS WIND TURBINE - A circulation controlled vertical axis wind turbine is presented. The circulation controlled vertical axis wind turbine comprise one or more airfoils in communication with the turbine via a rotatable support shaft and an airfoil support structure. The one or more airfoils have a blowing slot disposed near the trailing edge, and a controller and control means modulates a flow of air between the blowing slot and an internal cavity of the airfoil. | 01-19-2012 |
20120045329 | METHOD FOR CIRCULATION CONTROLLED VERTICAL AXIS AND TURBINES - A method of controlling a vertical axis wind turbines using circulation control is presented. The comprising monitoring environmental conditions and the vertical axis wind turbine to determine a current system state, and selectively blowing air through a blowing slot of a blade of the vertical axis wind turn based on the current system state to achieve a desired system state. | 02-23-2012 |
Daniel J. Nawrocki, Chicopee, MA US
Patent application number | Description | Published |
---|---|---|
20090081379 | Compositions and processes for manufacturing printed electronics - The present invention is directed to a printable composition, comprising: 0.5 to 60 wt % of a polymer selected from the group consisting of epoxy, Novolac and poly(dimethylglutarimide); and 40-99.5 wt % of a solvent composition comprising (1) a high boiling point solvent having a flash point greater than about 10° C. and a boiling point greater than about 130° C. and (2) a low boiling point solvent having a flash point less than 30° C. and a boiling point less than or equal to 130° C., all weight percents based on the total weight of the composition. The present invention is also directed to methods of forming patterned substrates using the above compositions. The compositions of the invention are useful for printing electronic materials onto a substrate using a piezo-electric printer. | 03-26-2009 |
20110267409 | Compositions and processes for manufacturing printed electronics - The present invention is directed to a printable composition, comprising: 0.5 to 60 wt % of a polymer selected from the group consisting of epoxy, Novolac and poly(dimethylglutarimide); and 40-99.5 wt % of a solvent composition comprising (1) a high boiling point solvent having a flash point greater than about 10° C. and a boiling point greater than about 130° C. and (2) a low boiling point solvent having a flash point less than 30° C. and a boiling point less than or equal to 130° C., all weight percents based on the total weight of the composition. The present invention is also directed to methods of forming patterned substrates using the above compositions. The compositions of the invention are useful for printing electronic materials onto a substrate using a piezo-electric printer. | 11-03-2011 |
20140302430 | EPOXY FORMULATIONS AND PROCESSES FOR FABRICATION OF RELIEF PATTERNS ON LOW SURFACE ENERGY SUBSTRATES - The present invention is directed to a permanent epoxy photoresist composition useful for making negative-tone, permanent photoresist relief patterns on low surface energy polymer substrates, comprising: (A) one or more epoxy resins according to Formulas I-VI, (B) one or more cationic photoinitiators; (C) one or more film casting solvents; and (D) one or more fluorinated compounds. The present invention is also directed to methods of forming a permanent photoresist relief pattern on a low surface energy polymer substrate using the disclosed composition. | 10-09-2014 |
20150024326 | PHOTOIMAGEABLE COMPOSITIONS AND PROCESSES FOR FABRICATION OF RELIEF PATTERNS ON LOW SURFACE ENERGY SUBSTRATES - The present invention is directed to a permanent photoimageable compositions and the cured products thereof useful for making negative-tone, permanent photoresist relief patterns on low surface energy polymer substrates, comprising: (A) one or more alkali soluble, film forming resins or one or more film forming resins that become soluble in alkali solutions by action of an acid, (B) one or more cationic photoinitiators, (C) one or more film casting solvents, and (D) one or more fluorinated compounds. The present invention is also directed to methods of forming a permanent photoresist relief pattern on a low surface energy polymer substrate using the disclosed compositions. | 01-22-2015 |
David Brian Nawrocki, Fleetwood, PA US
Patent application number | Description | Published |
---|---|---|
20140110421 | MAGNETIC DRAIN PLUG HOLDER - A drain plug holding device that includes a magnet and flexible line enclose in a heat shrinkable tube. The flexible line includes a swivel component and connecting component secured to the unencumbered end of the flexible line. A second magnet and flexible line enclosed in a heat shrinkable tube is connected to the first magnet and flexible line assembly via a connecting component. | 04-24-2014 |
Denise Nawrocki, Annandale, NJ US
Patent application number | Description | Published |
---|---|---|
20100143396 | Method for Preparing a Covalently Cross Linked Oligomer of Amyloid Beta Peptides - The invention relates to a method for the preparation of a stabilized cross-linked oligomer of amyloid beta using a near-zero length bifunctional cross-linking agent for use as an immunogen for the generation of antibodies for the treatment of Alzheimer's Disease and other conditions related to abnormal amyloid beta aggregation. A preferred bifunctional cross-linking agent is 1,5-difluoro-2,4-dinitrobenzene (DFDNB). | 06-10-2010 |
Denise Nawrocki, West Point, PA US
Patent application number | Description | Published |
---|---|---|
20100240868 | Composition and Method for a Producing Stable Amyloid Beta Oligomers of High Molecular Weight - The invention relates to a method for the preparation of a stable, soluble amyloid beta (Aβ) oligomer and composition thereof for use as an antigen for the generation of antibodies for the treatment of Alzheimer's disease and other conditions related to abnormal amyloid beta aggregation. The method which uses a pH in excess of 7.0 and high concentrations of Aβ, optionally includes the use of divalent anions or a helix-inducing solvent to form the oligomers. The stable, soluble Aβ oligomers produced by the method herein have a particle size of 10 to 100 nm in diameter, when measured by a dynamic light scattering technique, and a molecular weight of 100 to 500 kDa. | 09-23-2010 |
Denise K. Nawrocki, Annandale, NJ US
Patent application number | Description | Published |
---|---|---|
20090232795 | 1B20 PCSK9 ANTAGONISTS - Antagonists of human proprotein convertase subtilisin-kexin type 9 (“PCSK9”) are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. | 09-17-2009 |
20090246192 | 1D05 PCSK9 antagonists - Antagonists of human proprotein convertase subtilisin-kexin type 9 (“PCSK9”) are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. | 10-01-2009 |
20120301461 | 1D05 PCSK9 ANTAGONISTS - Antagonists of human proprotein convertase subtilisin-kexin type 9 (“PCSK9”) are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. | 11-29-2012 |
20130071379 | 1B20 PCSK9 ANTAGONISTS - Antagonists of human proprotein convertase subtilisin-kexin type 9 (“PCSK9”) are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. | 03-21-2013 |
20140220027 | 1D05 PCSK9 ANTAGONISTS - Antagonists of human proprotein convertase subtilisin-kexin type 9 (“PCSK9”) are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. | 08-07-2014 |
Diane Nawrocki, Tinton Falls, NJ US
Patent application number | Description | Published |
---|---|---|
20080260168 | METHOD AND APPARATUS FOR PROVIDING PRIVACY FOR TELEPHONE CONVERSATIONS - A method and apparatus for providing privacy for telephone conversations over communication networks is disclosed. For example, a telephony endpoint device comprises a microphone for receiving an audio signal and a gain boost circuit, coupled to the microphone, for applying a gain boost to the audio signal. The telephony endpoint device also comprises a switch, coupled to the gain boost circuit, wherein operating the switch will control whether the gain boost is to be applied to the audio signal. | 10-23-2008 |
20160057263 | METHOD AND APPARATUS FOR PROVIDING PRIVACY FOR TELEPHONE CONVERSATIONS - A method and apparatus for providing privacy for telephone conversations over communication networks is disclosed. For example, a telephony endpoint device comprises a microphone for receiving an audio signal and a gain boost circuit, coupled to the microphone, for applying a gain boost to the audio signal. The telephony endpoint device also comprises a switch, coupled to the gain boost circuit, wherein operating the switch will control whether the gain boost is to be applied to the audio signal. | 02-25-2016 |
Gregory J. Nawrocki, Winfield, IL US
Patent application number | Description | Published |
---|---|---|
20090254564 | Initial Content Customization Apparatus and Method - A hardware platform ( | 10-08-2009 |
20100004998 | Apparatus Pertaining to Identifying Information, Corresponding Characterizing Information, and Corresponding Modification of a Presentation that is Commonly Shared by a Plurality of End Users, and a Corresponding Method - A control circuit serves to receive data messages in conjunction with a corresponding source identifier from each of a plurality of sources (wherein the plurality of sources each have, at the time of sourcing their respective data message, a corresponding end user who is presently sharing a common presentation with others of the end users). The control circuit uses the source identifier to determine additional identifying information for at least a substantial number of these end users and then uses that additional identifying information to determine characterizing information for at least a substantial number of the end users. This characterizing information can then be used to modify the common presentation (for example, by controlling particular items of promotional content that comprise a part of the presentation). | 01-07-2010 |
Jesse Nawrocki, Annandale, NJ US
Patent application number | Description | Published |
---|---|---|
20160120543 | METHOD FOR APPROXIMATING WOUNDS - A method for approximating a wound using a uni-directional, barbed wound closure device having a needle and a stop element. The method includes taking a first pass by entering intact tissue at a location in proximity to the first apex and exiting in intact tissue at a location away from and above said first apex, pulling the wound closure device until the stop element is seated above the tissue plane, moving back toward the first apex and taking at least a second pass in a direction substantially perpendicular to the first pass at a location above or adjacent to the first apex, moving in a direction toward the second apex, approximating the wound using a continuous suturing pattern, moving toward the first apex, taking at least two passes across the wound, and cutting off a free end of the wound closure device in proximity to a surface of the tissue. | 05-05-2016 |
John Richard Nawrocki, Ocala, FL US
Patent application number | Description | Published |
---|---|---|
20090014400 | HOOK/HANGER COMPONENT MOUNTING SYSTEMS, COMPONENTS THEREOF, AND RELATED METHODS - According to various aspects of the present disclosure, there are provided various embodiments of attachment members, hooks, hanger components, mounting systems, and related methods. In one exemplary embodiment, a system generally includes a track standard, a hanger component having at least two spaced-apart bar portions, and an attachment member slidably engagable to the track standard. The attachment member includes first and second recessed portions configured for trapping the corresponding spaced-apart bar portions between the track standard and the attachment member when the attachment member is engaged to the track standard. With this trapping, the attachment member and hanger component may be collectively slidably movable along the track standard. | 01-15-2009 |
Michael Nawrocki, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20140065661 | AUTOMATED WELL PLATE - Disclosed in an embodiment herein is a well plate system including a well plate device, including three plates disposed above one another. The two top plates include wells disposed therein which are in fluid communication with one another, and which when the device is in a resting position, the second plate rests on top of the third plate to create a fluid sealed well. The third plate includes fluid drainage openings, such that when the system is in an activated position, the plates are moved such that the fluid within the wells exits through these openings. The system can be fully automated, and can include one or more motors to control movement of the plates. The system can also operate manually with a hinge connected to the plates. | 03-06-2014 |
Paul Nawrocki, Rossford, OH US
Patent application number | Description | Published |
---|---|---|
20140020734 | METHOD AND APPARATUS PROVIDING AN EXTRUDED EDGE SEAL ON A PHOTOVOLTAIC MODULE - An edge seal extruded onto at least a portion of one or more edges of a photovoltaic module is disclosed. A method for making a photovoltaic module comprising an extruded edge seal is also disclosed. | 01-23-2014 |
Shiri Nawrocki, Tenafly, NJ US
Patent application number | Description | Published |
---|---|---|
20150313822 | ZINC AMINO ACID COMPLEX WITH CYSTEINE - Provided are compositions, e.g., oral and personal care products, comprising (i) a tetrabasic zinc-amino acid or trialkyl glycine-halide complex, and (ii) cysteine in free or in orally or cosmetically acceptable salt form, together with methods of making and using the same. | 11-05-2015 |
20150313827 | PERSONAL CLEANSING COMPOSITIONS CONTAINING ZINC AMINO ACID/TRIMETHYLGLYCINE HALIDE - Provided is a personal cleansing composition for application to the skin which comprises a zinc X halide present in an amount to provide at least 0.36 weight % of the composition of zinc, and a surfactant, wherein X is an amino acid or trimethylglycine. Methods of making and using the compositions are also provided. The zinc X halide is can be used to deliver zinc salts to reduce or prevent sunburn, kill bacteria, or reduce perspiration. | 11-05-2015 |
Steffan Nawrocki, San Antonio, TX US
Patent application number | Description | Published |
---|---|---|
20110275696 | Thioxanthone-Based Autophagy Inhibitor Therapies to Treat Cancer - The present specification provides compositions comprising a thioxanthone-based autophagy inhibitor and/or a cancer therapeutic autophagy inducing compound, pharmaceutical kits comprising these compositions, and methods of treating cancer using such compounds, compositions and kits. Additionally, the present specification provides methods of treating cancer using a thioxanthone-based autophagy inhibitor and a radiotherapy. | 11-10-2011 |
20140106003 | Thioxanthone-Based Autophagy Inhibitor Therapies to Treat Cancer - The present specification provides compositions comprising a thioxanthone-based autophagy inhibitor and/or a cancer therapeutic autophagy inducing compound, pharmaceutical kits comprising these compositions, and methods of treating cancer using such compounds, compositions and kits. Additionally, the present specification provides methods of treating cancer using a thioxanthone-based autophagy inhibitor and a radiotherapy. | 04-17-2014 |